Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL450918 | 1.00 | TAAR1 (0.42) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL2406731 | 1.00 | TAAR1 (0.42) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL16202960 | 0.76 | TAAR1 (0.41) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL16202956 | 0.76 | TAAR1 (0.41) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL11859945 | 0.76 | TAAR1 (0.41) | TAAR1KDM4EADRA2AADRA2CCYP2D6 | |
| SCHEMBL12053468 | 0.74 | MEN1 (0.40) | KDM4EHIF1AALDH1A1 | |
| SCHEMBL2561541 | 0.74 | CYP3A4 (0.44) | CYP2D6LMNAALDH1A1TSHR | |
| SCHEMBL2560254 | 0.74 | IDO1 (0.39) | LMNAALDH1A1 | |
| SCHEMBL2554184 | 0.74 | CYP2A6 (0.40) | ALDH1A1 | |
| SCHEMBL3901288 | 0.74 | ADRB2 (0.52) | LMNAHIF1ATSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 160 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113461735-B | Ionic chiral mononuclear metal platinum complex, and preparation method and application thereof | 中国科学院化学研究所 | 2022-07-12 | — | — | CN | claimed |
| EP-3269724-B1 | MONONUCLEAR IRON COMPLEX AND ORGANIC SYNTHESIS REACTION USING SAME | UNIV KYUSHU NAT UNIV CORP (JP) | 2020-04-22 | — | — | EP | claimed |
| EP-3118205-B1 | MONONUCLEAR RUTHENIUM COMPLEX AND ORGANIC SYNTHESIS REACTION USING SAME | UNIV KYUSHU NAT UNIV CORP (JP) | 2020-04-22 | — | — | EP | claimed |
| US-9884316-B2 | Mononuclear ruthenium complex and organic synthesis reaction using same | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2018-02-06 | — | — | US | claimed |
| US-20170320908-A1 | SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES | ENCYCLE THERAPEUTICS INC. (CA) | 2017-11-09 | — | — | US | claimed |
| EP-3221335-A1 | SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES | Encycle Therapeutics (CA) | 2017-09-27 | — | — | EP | claimed |
| WO-2016079682-A1 | SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES | ENCYCLE THERAPEUTICS (CA) | 2016-05-26 | — | — | WO | claimed |
| US-9260479-B2 | Cyclic amino acid molecules and methods of preparing the same | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2016-02-16 | — | — | US | claimed |
| WO-2012109735-A1 | METHODS OF PREPARING CYCLIC AMINO ACID MOLECULES USING ARYLBORONIC OR ARYLBORINIC ACID CATALYSTS | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2012-08-23 | — | — | WO | claimed |
| US-20120065366-A1 | CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME | THE GOVERNING COUNCIL OF THE UNIVERSITY OF TORONTO (CA) | 2012-03-15 | — | — | US | claimed |
| US-5525688-A | ALLYLNICKEL COUNTERION COMPLEX REACTED WITH HALOGENATED KETONE | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 1996-06-11 | — | — | US | claimed |
| US-12296325-B2 | Catalyst for hydrosilylation reaction, hydrogenation reaction, and hydrosilane reduction reaction | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2025-05-13 | — | — | US | disclosed |
| EP-3184172-B1 | HYDROSILYLATION IRON CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-09-04 | — | — | EP | disclosed |
| EP-3195932-B1 | HYDROSILYLATION REACTION CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-08-21 | — | — | EP | disclosed |
| EP-3323505-B1 | HYDROSILYLATION REACTION CATALYST | UNIV KYUSHU NAT UNIV CORP (JP) | 2024-07-17 | — | — | EP | disclosed |
| US-4434317-A | Separation and recovery of unsaturated hydrocarbons by copper (I) complexes | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1984-02-28 | — | — | US | disclosed |
| US-4425281-A | Copper or silver complexes with fluorinated diketones and unsaturated ligands | EXXON RESEARCH AND ENGINEERING CO. (US) | 1984-01-10 | — | — | US | disclosed |
| US-4385005-A | Process for separating unsaturated hydrocarbons using copper or silver complexes with fluorinated diketonates | EXXON RESEARCH AND ENGINEERING CO. (US) | 1983-05-24 | — | — | US | disclosed |
| EP-0070638-A1 | Copper or silver complexes with fluorinated diketonates and unsaturated hydrocarbons | EXXON RESEARCH AND ENGINEERING COMPANY (US) | 1983-01-26 | — | — | EP | disclosed |
| US-4018757-A | ANTIINFLAMMATORY AGENTS | E. R. SQUIBB & SONS, INC. (US) | 1977-04-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12296325-B2 | Catalyst for hydrosilylation reaction, hydrogenation reaction, and hydrosilane reduction reaction | H1-0, HVCN1, H1-2 | TAAR1 933/4885KDM4E 3974/4885ADRA2A 2963/4885 |
| US-20120065366-A1 | CYCLIC AMINO ACID MOLECULES AND METHODS OF PREPARING THE SAME | DNPEP, ANPEP, BCAT1 | TAAR1 2557/4885KDM4E 4419/4885ADRA2A 4494/4885 |
| US-20170320908-A1 | SOLID PHASE SYNTHESIS OF CYCLIC AMINO ACID MOLECULES | MAX, BCAT1, ASNS | TAAR1 3562/4885KDM4E 3926/4885ADRA2A 4694/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.